Physician profile
Ryan E Wissner
NPI 1811309958
$1,805.03
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $178 · 2023: $22.16 · 2024: $33.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $351.75 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $306.81 | 2019-2020 | |
| Glaxosmithkline, LLC. | $218.15 | 2019-2020 | |
| Novo Nordisk INC | $145.36 | 2019-2024 | Wegovy |
| Lilly USA, LLC | $138.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.71 | 2019-2020 | |
| Amgen INC. | $84.38 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.26 | 2019-2020 | |
| Amarin Pharma, INC. | $53.78 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $51.28 | 2019 | |
| Horizon Therapeutics Plc | $37.99 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $29.50 | 2019-2020 | |
| Sanofi Pasteur INC. | $28.53 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $27.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.50 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $24.03 | 2019 | |
| Abbott Laboratories | $22.16 | 2023 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $19.20 | 2019 | |
| Astellas Pharma US INC | $18.64 | 2020 | |
| Neurocrine Biosciences, INC. | $16.75 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.55 | 2020 | |
| Shire North American Group INC | $12.08 | 2019 | |
| Mylan Specialty L.P. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wissner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.